Bio Roundup: Funding Frenzy, Opioid Summit, Celgene Woes & More
Xconomy
MARCH 2, 2018
The money came from a wide range of backers, not just traditional biotech venture firms. billion, a figure compiled in the Venture Monitor Report. Biotech startups rolled in cash this week. By our count, investors put more than $800 million into life-sciences startups in four days.
52 
Let's personalize your content